Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M333,891Revenue (TTM) $M71,890Net Margin (%)22.8Altman Z-Score--
Enterprise Value $M333,891EPS (TTM) $5.9Operating Margin %29.4Piotroski F-Score--
P/E(ttm)20.9Beneish M-Score--Pre-tax Margin (%)27.6Higher ROA y-yN
Price/Book4.610-y EBITDA Growth Rate %3.3Quick Ratio--Cash flow > EarningsN
Price/Sales4.85-y EBITDA Growth Rate %7.0Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow34.3y-y EBITDA Growth Rate %-9.3ROA % (ttm)12.0Higher Current Ratio y-yN
Dividend Yield %2.6PEG3.0ROE % (ttm)22.7Less Shares Outstanding y-yN
Payout Ratio %54.0Shares Outstanding M2,721ROIC % (ttm)31.4Gross Margin Increase y-yN

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

JNJ is held by these investors:



JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stoffels PaulusExec VP, Chief Scientific Off 2017-02-15Sell22,000$117.294.64view
Ullmann Michael HExec VP, General Counsel 2017-02-01Sell21,735$112.888.73view
PRINCE CHARLESDirector 2016-10-21Buy875$114.117.55view
Caruso Dominic JExec VP, Finance; CFO 2016-07-26Sell41,146$125.01-1.82view
Kapusta Ronald AController, CAO 2016-07-22Sell2,935$125.01-1.82view
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.035.77view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.795.99view
Kapusta Ronald AController, CAO 2016-05-10Sell3,957$114.776.94view
Stoffels PaulusChief Scientific Officer 2016-02-17Sell125,000$102.4319.82view
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.1217.87view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Dow Jones Leads Market Gains on Thursday Feb 23 2017 
    3 Dividend Stocks for 2017 Feb 21 2017 
    Under the Microscope: Gilead's Recent Dividend Increase Feb 15 2017 
    4 Companies Affected by Strength of the US Dollar Feb 13 2017 
    4 Companies That Will Benefit From Trump’s Repatriation Tax Reform Feb 13 2017 
    3 Dividend Stocks for 2017 Feb 13 2017 
    GuruFocus Interview: Orbimed Guru Sam Isaly on Investing in New Era of Healthcare Feb 15 2017 
    Beaten-Down Valuation and a 3% Dividend Yield Feb 07 2017 
    Merck: Analyzing 2016 Performance and Outlook for 2017 Feb 04 2017 
    4 Best Stocks for Value Investors This Week Jan 29 2017 

    More From Other Websites
    Pfizer’s Valuation after Its 4Q16 Earnings Release Feb 24 2017
    Johnson & Johnson (JNJ) Up 6% Since Earnings Report: Can It Continue? Feb 24 2017
    Morningstar's 5 Favorite Foreign-Stock ETFs Feb 24 2017
    Dow Jones Leads Market Gains on Thursday Feb 23 2017
    United Therapeutics feels squeeze from increased pulmonary hypertension competition Feb 23 2017
    Dow logs 10th straight record, but Nasdaq stumbles a second day Feb 23 2017
    Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday Feb 23 2017
    8 Dow Dividend Stocks You Can Buy and Hold Forever Feb 23 2017
    [$$] Fusion Pharmaceuticals Raises $25 Million for Targeted Cancer Therapies Feb 23 2017
    Cramer: Buyers for Bristol-Myers Are Few and Far Between Feb 22 2017
    Genmab and J&J's cancer drug set for blockbuster sales this year Feb 22 2017
    Genmab and J&J's cancer drug set for blockbuster sales this year Feb 22 2017
    Genmab's Darzalex could achieve peak annual sales of $9 billion - CEO Feb 22 2017
    Genmab's Darzalex could achieve peak annual sales of $9 bln -CEO Feb 22 2017
    10 Companies With The Best Corporate Reputations Feb 22 2017
    3 Dividend Stocks for 2017 Feb 21 2017
    Bristol-Myers Buys Back Shares, Shuffles Board Feb 21 2017
    Torax Medical agrees to sell to Johnson & Johnson subsidiary Feb 21 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)